There's a renewed push for apprenticeship programs in the U.S., one supporters say can address a shortage of skilled workers and the financial burden on young people today.
An FDA advisory board recommended withdrawing government approval for the breast cancer drug, Avastin. Pros and cons of the decision and its implications for FDA’s accelerated approval process to treat serious and life threatening diseases.
- Dr. Peter Bach attending physician and director of the Center for Health Policy and Outcomes at Memorial Sloan-Kettering Cancer Center, and a former adviser to Medicare.
- Dr. Carolyn Hendricks a medical oncologist affiliated with Suburban Hospital in Bethesda.
- William Hubbard former associate commissioner for the Food and Drug Administration; spokesperson for the Alliance for a Stronger FDA
- Gardiner Harris science reporter for "The New York Times" and author of the mystery novel 'Hazard.'
Most Recent Shows
The Centers for Disease Control reported the number of Americans who died from heroin overdoses quadrupled in the decade ending in 2013. We look at what's behind the nation's surge in heroin addiction and what some communities are doing to fight back.
A writer explores his father's mysterious imprisonment, and accusations that he was spying for the CIA, in revolutionary-era Iran.
A lame duck, with diminished power to get anything done: This is how many had expected to describe President Barack Obama in his final two years in office. But Obama has had a string of recent victories, and now, he’s setting his sights on other issues. We look at the president's evolution and his political priorities for the remainder of his term.